enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Cancer immunotherapy - Wikipedia

   en.wikipedia.org/wiki/Cancer_immunotherapy

   Cancer immunotherapy (immuno-oncotherapy) is the stimulation of the immune system to treat cancer, improving the immune system's natural ability to fight the disease. [1] It is an application of the fundamental research of cancer immunology ( immuno-oncology ) and a growing subspecialty of oncology .

3. List of antineoplastic agents - Wikipedia

   en.wikipedia.org/wiki/List_of_antineoplastic_agents

   Non-small cell lung cancer, oesophageal cancer, uterine cervical cancer, head and neck cancer and urothelial cancer: Nephrotoxicity, myelosuppression and nausea and vomiting (30-90%). Oxaliplatin: IV: Reacts with DNA, inducing apoptosis, non-cell cycle specific. Colorectal cancer, oesophageal cancer and gastric cancer

4. List of therapeutic monoclonal antibodies - Wikipedia

   en.wikipedia.org/wiki/List_of_therapeutic...

   This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.

5. Immunotherapy improves survival in people with advanced ... - AOL

   www.aol.com/immunotherapy-improves-survival...

   The regimen, which involves the immunotherapy drug nivolumab along with three different chemotherapies, was found to result in a two-year progression-free survival rate of 92% in a phase three ...

6. Immunotherapy - Wikipedia

   en.wikipedia.org/wiki/Immunotherapy

   Immunotherapy or biological therapy is the treatment of disease by activating or suppressing the immune system.Immunotherapies designed to elicit or amplify an immune response are classified as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies.

7. US FDA approves Amgen drug for small cell lung cancer - AOL

   www.aol.com/news/us-fda-approves-amgen-drug...

   The U.S. Food and Drug Administration on Thursday granted accelerated approval to Amgen's tarlatamab, a targeted immunotherapy for adults in the advanced stages of hard-to-treat small cell lung ...